Literature DB >> 22392487

Vascular endothelial growth factor gene polymorphisms and endometriosis risk: a meta-analysis.

Shoujun Liang1, Yin Huang, Yujuan Fan.   

Abstract

PURPOSE: The vascular endothelial growth factor (VEGF) gene polymorphism has been reported to be associated with endometriosis risk. The purpose of the present study was to perform a comprehensive meta-analysis to explore whether VEGF gene polymorphisms confer risk to endometriosis.
METHODS: By searching PubMed and EMBASE databases, a total of 11 studies were identified. Crude odds ratio (OR) and their corresponding 95% confidence intervals (CI) for VEGF gene polymorphisms and endometriosis risk were calculated. RESULT: An association of VEGF gene +936TC polymorphism with endometriosis was found (Fixed-effect model: TT + TC vs. CC: OR 1.184, 95% CI 1.027-1.366, P = 0.020; TC vs. CC: OR 1.187, 95% CI 1.024-1.375, P = 0.023. Random-effect model: TT + TC vs. CC: OR 1.203, 95% CI 1.003-1.443, P = 0.046; TC vs. CC: OR 1.188, 95% CI 1.021-1.382, P = 0.026). No association between VEGF genes -460CT, +405CG, -2578AC, -1154GA polymorphisms and endometriosis was observed.
CONCLUSION: Our results indicate that VEGF +936TC gene polymorphism is a risk factor for endometriosis, and not -460CT, +405CG, -2578AC, -1154GA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22392487     DOI: 10.1007/s00404-012-2270-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  7 in total

1.  Involvement of vascular endothelial growth factor -460 C/T, +405 G/C and +936 C/T polymorphisms in the development of endometriosis.

Authors:  Malgorzata Szczepańska; Adrianna Mostowska; Przemyslaw Wirstlein; Jana Skrzypczak; Paweł P Jagodziłski
Journal:  Biomed Rep       Date:  2014-12-19

2.  Association of vascular endothelial growth factor (VEGF) Gene polymorphisms and expression with the risk of endometriosis: a case-control study.

Authors:  Batool Hossein Rashidi; Negar Sarhangi; Soheila Aminimoghaddam; Fedyeh Haghollahi; Tahereh Naji; Mahsa M Amoli; Maryam Shahrabi-Farahani
Journal:  Mol Biol Rep       Date:  2019-04-22       Impact factor: 2.316

3.  The association between vascular endothelial growth factor (VEGF) +405G>C genetic polymorphism and endometriosis.

Authors:  Fang Fang; Lili Gong; Xiaojuan Wang; Ling Zhang
Journal:  Exp Biol Med (Maywood)       Date:  2015-01-07

4.  Natural history of urinary incontinence from first childbirth to 30-months postpartum.

Authors:  Krishna Patel; Jaime B Long; Sarah S Boyd; Kristen H Kjerulff
Journal:  Arch Gynecol Obstet       Date:  2021-06-27       Impact factor: 2.344

5.  Role of vascular endothelial growth factor polymorphisms (-2578C>A, -460 T>C, -1154G>A, +405G>C and +936C>T) in endometriosis: a case-control study with Brazilians.

Authors:  Jamila Alessandra Perini; Jessica Vilarinho Cardoso; Plínio Tostes Berardo; Rosane Vianna-Jorge; Luiz Eurico Nasciutti; Marta Bellodi-Privato; Daniel Escorsim Machado; Mauricio Simões Abrão
Journal:  BMC Womens Health       Date:  2014-09-26       Impact factor: 2.809

Review 6.  Anti-Angiogenic Alternative and Complementary Medicines for the Treatment of Endometriosis: A Review of Potential Molecular Mechanisms.

Authors:  Weilin Zheng; Lixing Cao; Zheng Xu; Yuanyuan Ma; Xuefang Liang
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-01       Impact factor: 2.629

7.  Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women.

Authors:  Ochuwa Adiketu Babah; Oyesola Oyewole Ojewunmi; Akinniyi Adediran Osuntoki; Melissa A Simon; Bosede Bukola Afolabi
Journal:  Hum Genomics       Date:  2021-10-30       Impact factor: 4.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.